insights_auto
Zašto je CRSP pao 6,21%?
Istražite detaljnijechevron_right
CRSP:NASDAQ
Crispr Therapeutics AG
48,56 USD
arrow_downward
−6,21%(−3,22) 1D
48,32 USD
arrow_downward
−0,49% (−0,24)bedtimeNakon radnog vremena
Zatvoreno: 5. stu, 16:00:00 GMT -5 · USD
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za CRSP...
Otvori
51,01 USD
Najviša
51,21 USD
Najniža
47,76 USD
Trž. kap.
4,71 mlr.
Prosj. kol.
1,44 mil.
Količina
2,15 mil.
52-tjed. najviša
63,45 USD
52-tjed. najniža
44,12 USD
EPS
−4,75 USD
Beta
1,49
Dionice u optjecaju
97,00 mil.
Broj djelatnika
393
Otvori
51,01 USD
Najviša
51,21 USD
Najniža
47,76 USD
Trž. kap.
4,71 mlr.
Prosj. kol.
1,44 mil.
Količina
2,15 mil.
52-tjed. najviša
63,45 USD
52-tjed. najniža
44,12 USD
EPS
−4,75 USD
Beta
1,49
Dionice u optjecaju
97,00 mil.
Broj djelatnika
393
Vijesti
Iz web-izvora i od partnera za vijesti
The Globe and Mail
·
prije 21 sat
Crispr Therapeutics AG (CRSP) Receives a Hold from RBC Capital
Yahoo Finance
·
prije 2 dana
CRSP's Q3 Loss Wider Than Expected, Sales Beat Estimates
Yahoo Finance
·
prije 3 dana
CRISPR Therapeutics AG (CRSP) Reports Q3 Loss, Tops Revenue Estimates
Yahoo Finance
·
prije 3 dana
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2026 Financial Results
Profil
CRISPR Therapeutics AG is a Swiss–American biotechnology company headquartered in Zug, Switzerland. The company does business as CRISPR Therapeutics, Inc. in the United States. It was one of the first companies formed to utilize the CRISPR gene editing platform to develop medicines for the treatment of various rare and common diseases. The company has approximately 500 employees and has offices in Zug, Switzerland; Boston, Massachusetts; San Francisco, California; and London, United Kingdom. Its manufacturing facility in Framingham, Massachusetts, won the Facilities of the Year Award award in 2022. The company’s lead program, exagamglogene autotemcel, or exa-cel, was granted regulatory approval by the US Food and Drug Administration in December 2023. Wikipedia
Crispr Therapeutics AG – informacije
Glavni izvršni direktorSamarth Kulkarni
Zaposlenici393
Osnovano2013
SjedišteZug, Zug, Švicarska
SektorHealth Care
Industry-
Web-lokacijacrisprtx.com